A consensus to this effect was reached at a meeting held on Friday between the drug pricing regulator, pharma lobby groups and industry associations, said people present at the meeting. The 30% cap on trade margins was preferred over other proposals such as imposing a flat 100% trade margin on all medicines, including those within price control.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/34prR2K
via IFTTT
0 comments:
Post a Comment